Heron Therapeutics Inc (HRTX)

Operating Income Growth

-981.82%

TTM · Period ending:

HRTX logo

HRTX Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-981.82%
HRTX TTM Operating Income YoY % (-43.90% → -981.82%)
High-resolution chart · PNG

HRTX operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Heron Therapeutics Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
-4,798.441%
-424.9543%
-284.0287%
-105.542%
-96.2362%
-48.9774%
-32.5926%
43.3333%
1,450%
700%
1,450%
175%
106.0606%
89.3617%
97.1429%
82.0225%
63.3333%
48.913%
16.6667%
-30.8824%
-20%
-10.8434%
9.6774%
34.6154%
27.1845%
20.1923%
12.2642%
-5.0505%
-25.6098%
-62.5%
-65.625%
-80%
-43.8596%
-28%
-56.0976%
-37.5%
-39.0244%
-4.1667%
10.8696%
14.8936%
8.8889%
-6.6667%
-53.3333%
51.0417%
43.038%
28.5714%
49.1525%
-209.6774%
-132.3529%
-80%
-43.9024%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.